DOSSIER · 13F Holders · Q2 2026
KROS
KEROS THERAPEUTICS INC
145 institutions still hold KEROS THERAPEUTICS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 492327101·145 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
145 institutions reported KROS in Q2 2026. Nantahala Capital Management, LLC leads at 16.7% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 8
125 more holders available. Log in →